About Enamine
Enamine is a company based in Kyiv (Ukraine) founded in 1991. Enamine offers products and services including Building Blocks Catalog, Compound Libraries, and Custom Synthesis. Enamine operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others.
- Latest Funding Round$2.35M (USD), Grant
Apr 2021
- Investors
Products & Services of Enamine
Enamine offers a comprehensive portfolio of products and services, including Building Blocks Catalog, Compound Libraries, and Custom Synthesis.
Catalog of over 300 thousand compounds for synthesis and research.
Pre-plated libraries for targeted drug discovery applications.
Tailored chemical synthesis using advanced technologies.
Apps and channels of Enamine
its YouTube channel Enamine Ltd has 279 subscribers and 18 videos.
Videos from Enamine
The most watched videos on Enamine's YouTube channel, Enamine Ltd (279 subscribers). Click a video to play it here.
More on Enamine Ltd.
Funding Insights of Enamine
- Total Rounds 6
- Last Round Grant — $2.35M
- First Round $444,717
(Jan 2016)
- Investors Count 1
All 6 funding rounds of Enamine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | $2.35M | Grant | – | – | |
| Mar 2021 | $282,514 | Grant | – | – | |
| Jan 2021 | $136,095 | Grant | – | – | |
| Sep 2017 | $573,929 | Grant | – | – | |
| Jan 2017 | $512,302 | Grant | – | – | |
| Jan 2016 | $444,717 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Enamine
Enamine has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Enamine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Enamine
33 people are tracked at Enamine (21 in leadership, 12 in team).
| Name | Role | Group |
|---|---|---|
David Leahy | CEO | Leadership |
Andrey Tolmachov | CEO and Founder | Leadership |
Andrii Poturai | Head Of Laboratory | Leadership |
Olesia Volovenko | Head Of Chiral Chromatography Laboratory | Leadership |
Boris Kesarev | Chief Solutions Architect | Leadership |
Andrii Yakymenko | Director Of Business Development, Asia Pacific | Leadership |
Vladimir Ivanov | Executive Vice President | Leadership |
Dave Hathaway | Director Of Business Development | Leadership |
Yuliia Holota 🇺🇦 | Head Of Adme/dmpk | Leadership |
Oksana Vasylenko | Vice President Of Operations | Leadership |
Andriy Frolov | Head Of Laboratory | Leadership |
Dave Lonergan | Director, Business Development | Leadership |
Iaroslava Kos | Director Of Business Development | Leadership |
Yurii Moroz | VP Of Sales And Marketing | Leadership |
Sergey Zozulya | Head Of Newtech Department | Leadership |
Evgeniy Chernyshenko | Head Of Unit | Leadership |
Ihor Tkachenko | Head Of Data Processing Division | Leadership |
Yarema Galushchak | Head Of Laboratory | Leadership |
Dmytro Radchenko | Head Of Parallel Chemistry | Leadership |
Dmitry Krotko | Creative Director | Leadership |
13 more people are available in the full profile.
Complete people profiles for Enamine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Enamine
3 dated milestones of Enamine across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Enamine is founded.
- Funding First funding round of $445K.
- Funding Latest funding round, Grant, of $2.4M.
Competitors of Enamine
Enamine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| aciesbio.com | 2006 | Ljubljana, Slovenia | – | – | Provider of drug discovery and development services to pharmaceutical, biotech, and food industries | |
| personalchemistry.com | 1998 | Uppsala, Sweden | $50.46M | – | Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. | |
| irbm.com | 2010 | Pomezia, Italy | – | – | Integrated drug discovery and preclinical development services are provided. | |
| nfil.in | 1967 | Mumbai, India | – | 1,476 | Fluorinated compounds are synthesized and manufactured customly for various industries. | |
| spirochem.com | 2011 | Zurich, Switzerland | – | – | Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry | |
| medicilon.com | 2004 | Pudong, China | – | – | Integrated drug discovery and preclinical services are provided. | |
| sapalaorganics.com | 2005 | Hyderabad, India | $734,962 | 219 | Research organization specializing in custom synthesis of various organic compounds | |
| liverpoolchirochem.com | 2014 | Liverpool, United Kingdom | $11.07M | 14 | Small organic molecules are supplied for biotech and pharmaceutical R&D. |
Detailed competitors of Enamine
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Enamine
The website of Enamine (enamine.net) receives about 58.1K visits a month.
- Monthly visits58.1K
▲ 5.9% vs previous month
Websites whose visitors overlap most with Enamine. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pqs-chem.com | pqs-chem.com | 100% | – | – | – |
| molport.com | 94% | 59.6K | #556,316 | View details | |
| lifechemicals.com | 89% | – | #3,037,311 | View details | |
| molsoft.com | 88% | 18.2K | #1,458,594 | View details | |
| tricliniclabs.com | 87% | – | #2,662,778 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 28 similar websites and full traffic analytics for Enamine
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Enamine
Complete news archive for Enamine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Enamine
10 companies that operate in the same segment as Enamine (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Enamine
Enamine was founded in 1991 and raised its 1st funding round 25 years after it was founded.
Enamine is headquartered in Kyiv, Ukraine.
David Leahy is the current CEO of Enamine.
Enamine is a drug discovery CRO offering a range of products and services for facilitating drug discovery and preclinical development. Their major products include screening compounds and building blocks which include over 2.2 million compounds (which include 27,000 fragments and 175,000 building blocks), while their major services include custom synthesis, lead optimization, and molecular modeling. Enamine has several compound libraries for fragment-based drug discovery (Rule of three, Golden fragment, fluorinated, brominated libraries, among several others), focused and targeted drug discovery (Ex: CNS-targeted, Nuclear receptor and Ion-channel libraries, among several others) and express lead-based drug discovery (novel lead-like libraries synthesised and delivered in 2-3 weeks). Enamines service portfolio includes Hit Follow-Up Support, Custom synthesis (Small molecules, intermediates, reference compounds, fragment libraries etc), bioanalytical and HTS screening services (through its subsidiary Bienta, which offers in vitro ADMET and pharmacokinetic assays (biochemical and cell-based assays)). Enamine has a partnership with Ukrainian company FCH Group for compound library synthesis. Actelions RD Spinoff, RD NewCo signed an agreement with Enamine in January 2017 for access to its novel building blocks and screening libraries for use in early drug discovery.
Enamine's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
Enamine offers Building Blocks Catalog, Compound Libraries, and Custom Synthesis.
Enamine has 1 investor. Key investors include European Union.
Enamine operates through Enamine Ltd..